BRADY ANN 4
4 · Theravance Biopharma, Inc. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
BRADY ANN
President, TBIL
Transactions
- Tax Payment
Ordinary Shares
2022-02-18$9.61/sh−8,369$80,426→ 110,319 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.